MCTA (Charming Medical) Stock Based Compensation: $0.00 Mil (TTM As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MCTA Charming Medical Ltd MCTA
29 GF Score
Price $29.36
! 6 Warning Signs
View Full Analysis

What is Charming Medical Stock Based Compensation?

Charming Medical MCTA -0.15% 29 Stock Based Compensation is $0.00 Mil as of Sep. 2025. GuruFocus rates MCTA with a GF Score™ of 29/100. The stock has 6 warning signs investors should review.

Charming Medical's Stock Based Compensation for the six months ended in Sep. 2025 was $0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Sep. 2025 was $0.00 Mil.

Charming Medical Stock Based Compensation Related Terms

Charming Medical Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Charming Medical's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Charming Medical Stock Based Compensation Chart

Charming Medical Annual Data
Trend Mar23 Mar24 Mar25
Stock Based Compensation
0.00 0.00 0.00

Charming Medical Semi-Annual Data
Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Stock Based Compensation Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
MCTA
29GF Score
Charming Medical Ltd MCTA
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Charming Medical Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Sep. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

What does a Stock Based Compensation of $0.00 Mil mean?
Charming Medical (MCTA) has a Stock Based Compensation of $0.00 Mil as of Sep. 2025. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Charming Medical and its competitors.
Is Charming Medical's Stock Based Compensation too high?
Charming Medical's current Stock Based Compensation is $0.00 Mil. Overall, Charming Medical has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Charming Medical's Stock Based Compensation compare to EHAB and CYH?
Charming Medical's Stock Based Compensation of $0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Healthcare Providers & Services company?
A good Stock Based Compensation depends on the Healthcare Providers & Services industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Charming Medical and its competitors. Charming Medical's current Stock Based Compensation is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Charming Medical stock overvalued right now?
Charming Medical (MCTA) has a current Stock Based Compensation of $0.00 Mil. The current Stock Based Compensation is $0.00 Mil. Charming Medical's overall GF Score™ is 29/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Charming Medical (MCTA), the current Stock Based Compensation is $0.00 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Charming Medical Business Description

Address 2-20 Paterson Street, Causeway Bay, Units 1803-1806, 18th Floor, Hang Lung Centre, Hong Kong, HKG
Charming Medical Ltd is a Hong Kong-based provider of Traditional Chinese Medicine (TCM)-inspired therapies and products. It offers a wide range of beauty, wellness, and postpartum services and products rooted and influenced by the principles and practices of TCM, such as the use of herbal ingredients, acupuncture techniques, Tuina massage, and dietary guidance. Its beauty, wellness, and postpartum services include but are not limited to womb-warming therapy, BTS (Beauty, Tailor-made, Slim) pelvic detox therapy, agarwood moxibustion therapy, TCM-inspired prenatal massage, and Indonesian traditional abdominal binding.
29GF Score

Get the complete analysis for MCTA

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$29.36
Price